<DOC>
	<DOCNO>NCT00897858</DOCNO>
	<brief_summary>RATIONALE : Studying sample cerebrospinal fluid patient cancer laboratory may help doctor identify biomarkers related cancer . PURPOSE : This laboratory study study cerebrospinal fluid protein angiogenesis protein young patient newly diagnose central nervous system tumor .</brief_summary>
	<brief_title>Studying Cerebrospinal Fluid Proteins Angiogenesis Proteins Young Patients With Newly Diagnosed Central Nervous System Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Investigate feasibility centrally collect process high-quality cerebrospinal fluid ( CSF ) sample pediatric patient newly diagnose central nervous system tumor proteomic study . - Identify protein marker might indicate presence brain tumor use CSF sample collect patient . OUTLINE : This multicenter study . Patients undergo cerebrospinal fluid ( CSF ) collection follow 5 site : lumbar , cervical , ommaya , intra-operative ( ventricular , cisternal ) , and/or external ventricular drain . CSF obtain within 8 week diagnosis prior ( concurrent ) initiation post-operative therapy ( exclude corticosteroid ) . CSF sample examine proteomic biomarkers 2D gel electrophoresis , low-mass fingerprinting , stable isotope label . PROJECTED ACCRUAL : A total 99 patient accrue study .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm CNS tumor follow histology : Diffuse pontine gliomas* Focal/infiltrative tumor , include follow : High lowgrade glioma Gangliogliomas Ependymomas Oligodendrogliomas Craniopharyngioma Dysembryoplastic neuroepithelial tumor Other lowgrade neoplasm Optic pathway gliomas* Seeding tumor , include follow : Germ cell tumor ( germinomas nongerminomas ) Embryonal tumor , include follow : Medulloblastoma Pineoblastoma Supratentorial primitive neuroectodermal tumor Atypical teratoid/rhabdoid tumor Other embryonal tumor NOTE : *Histological requirement waive Newly diagnose disease Cerebrospinal fluid ( CSF ) obtain part CSF diversion , initial diagnosis/staging , administration intrathecal chemotherapy ( initiation postoperative therapy ) PATIENT CHARACTERISTICS : Less 22 year age PRIOR CONCURRENT THERAPY : No prior radiotherapy chemotherapy Prior corticosteroid allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
	<keyword>untreated childhood visual pathway glioma</keyword>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>untreated childhood visual pathway hypothalamic glioma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>childhood central nervous system choriocarcinoma</keyword>
	<keyword>childhood central nervous system embryonal tumor</keyword>
	<keyword>childhood central nervous system germinoma</keyword>
	<keyword>childhood central nervous system mixed germ cell tumor</keyword>
	<keyword>childhood central nervous system teratoma</keyword>
	<keyword>childhood central nervous system yolk sac tumor</keyword>
</DOC>